314 related articles for article (PubMed ID: 8775529)
1. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
[TBL] [Abstract][Full Text] [Related]
2. Identical-twin bone marrow transplants for leukemia.
Gale RP; Horowitz MM; Ash RC; Champlin RE; Goldman JM; Rimm AA; Ringdén O; Stone JA; Bortin MM
Ann Intern Med; 1994 Apr; 120(8):646-52. PubMed ID: 8135448
[TBL] [Abstract][Full Text] [Related]
3. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
[TBL] [Abstract][Full Text] [Related]
5. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
6. Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Greinix HT; Keil F; Brugger SA; Reiter E; Linkesch W; Lechner K; Schneider B; Dieckmann KU; Fischer G; Schwarzinger I; Haas O; Hinterberger W; Mannhalter C; Geissler K; Hocker P; Jager U; Kalhs P
Ann Hematol; 1996 Feb; 72(2):53-9. PubMed ID: 8597607
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
[TBL] [Abstract][Full Text] [Related]
9. HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Marks DI; Hughes TP; Szydlo R; Kelly S; Cullis JO; Schwarer AP; Mackinnon S; Apperley J; Barrett AJ; Hows JM
Br J Haematol; 1992 Jul; 81(3):383-90. PubMed ID: 1390211
[TBL] [Abstract][Full Text] [Related]
10. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
Ringdén O; Labopin M; Gorin NC; Schmitz N; Schaefer UW; Prentice HG; Bergmann L; Jouet JP; Mandelli F; Blaise D; Fouillard L; Frassoni F;
Br J Haematol; 2000 Dec; 111(4):1130-7. PubMed ID: 11167752
[TBL] [Abstract][Full Text] [Related]
11. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
Szydlo R; Goldman JM; Klein JP; Gale RP; Ash RC; Bach FH; Bradley BA; Casper JT; Flomenberg N; Gajewski JL; Gluckman E; Henslee-Downey PJ; Hows JM; Jacobsen N; Kolb HJ; Lowenberg B; Masaoka T; Rowlings PA; Sondel PM; van Bekkum DW; van Rood JJ; Vowels MR; Zhang MJ; Horowitz MM
J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184
[TBL] [Abstract][Full Text] [Related]
12. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy.
Zhang MJ; Baccarani M; Gale RP; McGlave PB; Atkinson K; Champlin RE; Dicke KA; Giralt S; Gluckman E; Goldman JM; Klein JP; Herzig RH; Masaoka T; O'Reilly RJ; Rozman C; Rowlings PA; Sobocinski KA; Speck B; Zwaan FE; Horowitz MM
Br J Haematol; 1997 Oct; 99(1):23-9. PubMed ID: 9359497
[TBL] [Abstract][Full Text] [Related]
14. Chronic myeloid leukaemia treated by allogeneic bone marrow transplantation from histocompatible sibling donors--an invariably fatal malignancy rendered highly curable.
Szer J; Sheridan WP
Aust N Z J Med; 1991 Aug; 21(4):408-13. PubMed ID: 1953529
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin.
Finke J; Bertz H; Schmoor C; Veelken H; Behringer D; Wäsch R; Kunzmann R; Heidecker L; Lang H; Meyer-König U; Mertelsmann R
Br J Haematol; 2000 Oct; 111(1):303-13. PubMed ID: 11091217
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).
Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Deliliers GL; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Br J Haematol; 1996 Dec; 95(4):715-23. PubMed ID: 8982051
[TBL] [Abstract][Full Text] [Related]
17. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
[TBL] [Abstract][Full Text] [Related]
18. Changing results of HLA-identical sibling bone marrow transplantation in patients with haematological malignancy during the period 1981-1990.
Atkinson K; Biggs JC; Concannon AJ; Dodds AJ; Milliken S; Downs K; Marshall G; Wilson F; Young S; Ashby M
Aust N Z J Med; 1993 Apr; 23(2):181-6. PubMed ID: 8390831
[TBL] [Abstract][Full Text] [Related]
19. Reduced intensity thiotepa-cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age.
Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Mordini N; Berisso G; Bregante S; Frassoni F; Sessarego M; Fugazza G; Di Stefano F; Pitto A; Bacigalupo A
Br J Haematol; 2000 Jun; 109(4):716-21. PubMed ID: 10929020
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Hahn T; McCarthy PL; Zhang MJ; Wang D; Arora M; Frangoul H; Gale RP; Hale GA; Horan J; Isola L; Maziarz RT; van Rood JJ; Gupta V; Halter J; Reddy V; Tiberghien P; Litzow M; Anasetti C; Pavletic S; Ringdén O
J Clin Oncol; 2008 Dec; 26(35):5728-34. PubMed ID: 18981462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
